GO Annotation Review Summary: C. elegans Priority 3 Surveillance Immunity Genes

COMPLETE BIOLOGY_DOMAIN

Species: worm

GO Annotation Review Summary: C. elegans Priority 3 Surveillance Immunity Genes

Date: 2025-12-29
Reviewer: AI Gene Review Curator
Scope: Systematic review of 6 C. elegans innate immunity genes for GO annotation quality

Overview

This document provides a comprehensive curation summary for 6 Priority 3 C. elegans surveillance immunity genes. The genes encompass the major pathway components: master stress/immune transcription factor (daf-16), TGF-beta ligand (dbl-1), STAT-like transcription factor (sta-2), Tribbles kinase adapter (nipi-3), lysozyme effector (lys-7), and C-type lectin effector (clec-60).

Total annotations across 6 genes: 238
- daf-16: 144 annotations (IBA, IDA, IMP, IGI, IPI, NAS, TAS, IEA, IEP, IEP)
- dbl-1: 32 annotations (IBA, IMP, IGI, ISS, IEA)
- sta-2: 27 annotations (IBA, IMP, IDA, IPI, IEA)
- nipi-3: 18 annotations (IBA, IEA, IMP, IPI)
- lys-7: 18 annotations (IBA, IEA, IMP, IGI)
- clec-60: 1 annotation (IGI)

Summary of Curation Recommendations by Gene

1. DAF-16 (O16850) - FOXO Transcription Factor (144 annotations)

Gene Summary

DAF-16 is the C. elegans FOXO ortholog and master transcription factor downstream of the DAF-2/insulin-like signaling pathway. It integrates stress responses (oxidative stress, heat, starvation, UV) and immune defense. DAF-16 is a pluripotent regulator with roles spanning longevity, dauer formation, innate immunity, metabolism, and development. It functions as both a transcriptional activator and repressor depending on context.

Overall Assessment

The annotation set is comprehensive and well-curated, reflecting both IBA phylogenetic inferences and extensive experimental evidence. The collection includes some over-annotations and pleiotropic developmental roles that should be categorized as NON-CORE. The large annotation set (144) accurately reflects the pleiotropic nature of FOXO transcription factors.

Key Curation Issues

ISSUE 1: Protein Binding Annotations (Multiple entries)

Problem: Multiple generic GO:0005515 (protein binding) annotations with IPI evidence codes (rows 25-32, 108, 140)
Scope: At least 8-9 annotations
Recommendation:
- Action: REMOVE (generic) or MODIFY to specific interactions
- Rationale: Generic "protein binding" annotations lack functional specificity. Review each IPI interaction:
- PMID:15068796 with Q17941/Q2PJ68/Q9XTG7: These appear to be high-throughput yeast-two-hybrid interactions. Determine if mechanistically relevant.
- PMID:16777605, PMID:16860373, PMID:18358814: Map Q21921 interaction - this is FKH-1 (another forkhead protein). Keep but annotate as "forkhead protein binding" if validated.
- PMID:11124266 with P63101: Map to specific interacting protein. If it's 14-3-3, keep as specific GO:0071889.

Action Needed: Cross-reference with publications and InterAct database to replace with specific binding interactions (GO:0071889 for 14-3-3 binding, etc.)

ISSUE 2: Non-core Developmental/Pleiotropic Roles

Problem: Multiple developmental annotations (dauer, larval development, synaptic assembly) represent important biological roles but are peripheral to the core immune function for this review
Scope:
- GO:0040024 (dauer larval development) - rows 102, 145
- GO:0002119 (nematode larval development) - row 125
- GO:0061065/GO:0061066 (regulation of dauer larval development) - rows 92-93, 105
- GO:0008582/GO:0045887 (synaptic assembly at neuromuscular junction) - rows 71-73
- GO:0007614 (short-term memory) - row 94
- GO:0030431 (sleep) - rows 59-60
- GO:0060537 (muscle tissue development) - row 124

Recommendation:
- Action: KEEP_AS_NON_CORE (for all developmental annotations)
- Rationale: These represent well-documented pleiotropic roles of DAF-16, but in the context of the surveillance immunity pathway, they are secondary to immune function. Mark as non-core to focus annotation on the immune/stress resistance pathway.

ISSUE 3: Lifespan/Aging Annotations (Heavy over-representation)

Problem: GO:0008340 (determination of adult lifespan) appears excessively (rows 15, 50, 70, 84-86, 89, 95, 100, 111-112, 114, 133-134, 142-143 = 13+ entries with mixed evidence codes)
Scope: 13-14 distinct annotations
Recommendation:
- Action: CONSOLIDATE - Keep 3-4 strongest evidence entries (IMP codes); REMOVE redundant duplicates with weaker evidence
- Rationale: This massive over-representation reflects both the biological importance of DAF-16 in longevity and potential annotation redundancy. Multiple studies demonstrate DAF-16's role in lifespan through IMP/IGI evidence. The older IEP entries (row 136) are weak and redundant with IMP/IGI data.
- Specific guidance:
- KEEP: PMID:11747825 (IMP), PMID:11381260 (IMP), PMID:23665919 (IGI), PMID:22560223 (IMP)
- REMOVE: PMID:11747821 (IMP but older and superseded), row 136 (IEP - weak evidence)
- MODIFY: Some IGI entries may be context-specific (Worm var genetic backgrounds)

ISSUE 4: Vague/Overly Broad Process Terms

Problem: Several annotations are too general for specific function
Scope:
- GO:0010468 (regulation of gene expression) - row 58 (IMP, PMID:32963007)
- GO:0006355 (regulation of DNA-templated transcription) - rows 13, 120, 131
- GO:0006351 (DNA-templated transcription) - row 12

Recommendation:
- Action: MODIFY to specific processes
- Rationale: For a transcription factor, these broad terms are redundant with more specific annotations. Replace with specific pathway/target genes when possible.
- Examples: GO:0045087 (innate immune response), GO:0034599 (cellular response to oxidative stress), GO:0008286 (insulin receptor signaling pathway) are more informative.

ISSUE 5: Specific Immunity Annotations - WELL SUPPORTED

Annotations to ACCEPT with confidence:
- GO:0045087 (innate immune response) - rows 115, 23 (IMP, IEA with strong support)
- GO:0050829 (defense response to Gram-negative bacterium) - rows 57, 63, 117 (IMP/IGI)
- GO:0050830 (defense response to Gram-positive bacterium) - row 67 (IMP)
- GO:0031349 (positive regulation of defense response) - row 18 (IEA)
- GO:0002821 (positive regulation of adaptive immune response) - rows 121, 126 (IMP)
- GO:1900426 (positive regulation of defense response to bacterium) - row 98 (IMP)

These annotations are core functions with solid experimental evidence and should be retained as ACCEPT.

ISSUE 6: IBA Annotations Quality Check

IBA annotations present: Rows 2-5, 9-24 (multiple molecular_function, cellular_component, biological_process)
Assessment: Most IBA annotations are appropriately broad and phylogenetically sound:
- GO:0000981 (DNA-binding transcription factor activity, RNA polymerase II-specific) - ACCEPT (row 2)
- GO:0005634 (nucleus) - ACCEPT as is_active_in relationship (row 3)
- GO:0006357 (regulation of transcription by RNA polymerase II) - ACCEPT (row 4)
- GO:0008286 (insulin receptor signaling pathway) - ACCEPT (row 14, core pathway)
- GO:0008340 (determination of adult lifespan) - MODIFY (see above - over-annotated)
- GO:0009896, GO:0010883, GO:0034599, GO:0040015, GO:0042594, GO:0050778 - All reasonable IEA/ARBA annotations based on functional evidence

ISSUE 7: Location Annotations (nucleus/cytoplasm)

Problem: Multiple entries for nuclear (GO:0005634) and cytoplasmic (GO:0005737) localization with both is_active_in and located_in/colocalizes_with relationships
Scope: ~8-10 entries with multiple relationships
Recommendation:
- Action: CONSOLIDATE and standardize relationships
- Rationale: DAF-16 shuttles between cytoplasm and nucleus. Keep IDA entries from key studies (PMID:11124266, PMID:11381260, PMID:11747821). Use relationship types consistently:
- is_active_in for nucleus (transcriptional function)
- located_in for both when present
- Remove redundant NAS entries if IDA entries exist

ISSUE 8: Heat/Stress Response Annotations

Well-supported core functions:
- GO:0034605 (cellular response to heat) - rows 39, 138-139 (IMP/IDA) - ACCEPT
- GO:0006979 (response to oxidative stress) - row 79 (IGI)
- GO:0034599 (cellular response to oxidative stress) - rows 19, 101 (IEA/IGI) - ACCEPT
- GO:0009411 (response to UV) - rows 80, 135 (IGI/IDA) - ACCEPT
- GO:0042594 (response to starvation) - rows 21, 97 (IEA/IMP) - ACCEPT

These are core stress-response functions aligned with the surveillance immunity role and should all be ACCEPTED.

Action Count GO Terms Evidence
ACCEPT (core immune) ~15-18 GO:0045087, GO:0050829, GO:0050830, GO:0031349, stress responses IMP, IGI, IEA
KEEP_AS_NON_CORE ~20 Dauer, larval dev, synaptic assembly, memory, sleep IMP, IGI
MODIFY (broad to specific) ~5 GO:0010468, GO:0006355, GO:0006351 IMP
REMOVE (redundant) ~5-8 Duplicate lifespan entries, generic protein binding IEA, IPI
CONSOLIDATE ~15 Nuclear/cytoplasmic localization, 14-3-3 binding IDA, NAS, IPI

2. DBL-1 (G5EEL5) - TGF-beta/BMP Ligand (32 annotations)

Gene Summary

DBL-1 is the C. elegans ortho log of Drosophila decapentaplegic (Dpp) and vertebrate BMP2/4. It's a secreted TGF-beta superfamily ligand expressed primarily in neurons, signaling non-cell-autonomously to hypodermal cells through SMA-6 (type I) and DAF-4 (type II) receptors, activating the SMAD pathway for body size regulation. Beyond growth control, DBL-1 regulates innate immunity, lipid metabolism, and sexual differentiation.

Overall Assessment

The 32 annotations are well-organized with good balance between molecular function (growth factor/cytokine activity, receptor binding), cellular component (extracellular space), and biological processes (BMP pathway, immune responses, growth regulation). The annotations appropriately capture both developmental and immune roles.

Key Curation Issues

ISSUE 1: Growth/Development vs. Immune Annotations Balance

Problem: Most annotations (rows 4-27, 29-32) focus on body size/growth regulation and male tail morphogenesis, which represent the most extensively studied dbl-1 function, but are NOT core to surveillance immunity
Scope:
- GO:0040018 (positive regulation of multicellular organism growth) - rows 21, 26-27, 32 (4 entries)
- GO:0045138 (nematode male tail tip morphogenesis) - row 28
- GO:0045793 (positive regulation of cell size) - row 30
- GO:0046622 (positive regulation of organ growth) - row 31
- GO:0002119 (nematode larval development) - row 29
- GO:0042661 (regulation of mesodermal cell fate specification) - row 12
- GO:0032877 (positive regulation of DNA endoreduplication) - row 23

Recommendation:
- Action: KEEP_AS_NON_CORE (for all growth-related annotations)
- Rationale: These represent well-studied but non-immune dbl-1 functions. Appropriate to keep but mark as secondary to immune role in surveillance immunity context.

ISSUE 2: Immune Response Annotations - Core Functions

Annotations to ACCEPT:
- GO:0050832 (defense response to fungus) - row 14 (IMP, PMID:19198592)
- GO:0050829 (defense response to Gram-negative bacterium) - rows 15-16 (IMP, PMID:17975555) - Duplicate entries
- GO:0050830 (defense response to Gram-positive bacterium) - row 17 (IMP, PMID:17975555)
- GO:0045087 (innate immune response) - row 22 (IMP, PMID:19198592)
- GO:0010628 (positive regulation of gene expression) - row 7 (IMP, PMID:18158917) - in immune context

Recommendation:
- Action: ACCEPT all immune annotations
- Rationale: These demonstrate dbl-1's role in TGF-beta-mediated innate immunity. The fungal and bacterial defense responses are well-supported experimentally.
- Note: Rows 15-16 are duplicates (same GO term, evidence, and reference but recorded twice). Consolidate to single entry.

ISSUE 3: TGF-beta/BMP Pathway Core Annotations

Annotations to ACCEPT:
- GO:0030509 (BMP signaling pathway) - rows 4, 19 (IBA, ISS with phylogenetic support)
- GO:0005125 (cytokine activity) - row 2 (IBA)
- GO:0008083 (growth factor activity) - row 6 (IEA via InterPro)
- GO:0070700 (BMP receptor binding) - row 20 (ISS, PMID:9847238)
- GO:0005615 (extracellular space) is_active_in - row 3 (IBA)
- GO:0005576 (extracellular region) - row 5 (IEA)

Recommendation:
- Action: ACCEPT all pathway annotations
- Rationale: These capture the core molecular function of DBL-1 as a TGF-beta/BMP-like secreted signaling molecule.

ISSUE 4: Lipid Metabolism Annotations

Annotations present:
- GO:0019216 (regulation of lipid metabolic process) acts_upstream_of - row 8 (IMP, PMID:29162682)

Recommendation:
- Action: KEEP_AS_NON_CORE
- Rationale: Important but not core to surveillance immunity. DBL-1's role in lipid metabolism represents a secondary pleiotropic function.

ISSUE 5: Miscellaneous Process Annotations

Annotations to evaluate:
- GO:0010468 (regulation of gene expression) - row 13 (IMP, PMID:17526726)
- GO:0022604 (regulation of cell morphogenesis) - row 9 (IMP, PMID:24690231)
- GO:0030511 (positive regulation of TGF-beta receptor signaling pathway) - row 11 (IGI, PMID:28068334)
- GO:0045944 (positive regulation of transcription by RNA polymerase II) - row 10 (IMP, PMID:19198592)

Recommendation:
- Action: MODIFY or CONSOLIDATE
- Rationale: Some overlap with immune response annotations above. Rows 10 and 45944 likely redundant with immune pathway activation. Row 13 is too general; prefer specific processes.

ISSUE 6: ISS (Sequence Similarity) Annotations Quality

Annotations present: Rows 18-20 (ISS with PMID:9847238 reference to ortholog studies)

Recommendation:
- Action: ACCEPT with caution
- Rationale: ISS annotations (rows 18-20) are phylogenetically sound but refer to mammalian/Drosophila ortholog studies. The references are appropriate for TGF-beta/BMP pathway component inference. These are weaker than IMP evidence but reasonable.

Action Count GO Terms Evidence
ACCEPT (core function) ~8 GO:0030509, GO:0005125, GO:0008083, immune responses IBA, IEA, IMP
KEEP_AS_NON_CORE ~10 Growth (0040018, 0045793, 0046622), development, morphogenesis IMP, IGI
CONSOLIDATE ~2 Duplicate rows 15-16 (GO:0050829) IMP
REMOVE ~1 Redundant lipid metabolism if other pathway captured IMP

3. STA-2 (Q20977) - STAT-like Transcription Factor (27 annotations)

Gene Summary

STA-2 is a STAT-like transcription factor that uniquely functions in C. elegans epidermal immunity without JAK kinases (absent in C. elegans). Activated through unconventional SNF-12 transporter mechanism, STA-2 is sequestered at hemidesmosomes in normal conditions and released upon epidermal damage or fungal infection. It translocates to nuclei and activates antimicrobial peptide genes (especially nlp-29). STA-2 also participates in developmental signaling (ECM-to-nucleus pathway) during molts.

Overall Assessment

27 annotations are well-distributed and appropriate. The review must distinguish between sta-2's core epidermal immunity function and its secondary developmental roles. IBA annotations are phylogenetically reasonable given STAT family conservation, but some are over-applied to C. elegans specificity.

Key Curation Issues

ISSUE 1: Redundant IBA Annotations

Annotations present: Rows 2-9 (multiple IBA entries with GO_REF:0000033)
- GO:0005737 (cytoplasm) is_active_in
- GO:0006952 (defense response)
- GO:0042127 (regulation of cell population proliferation)
- GO:0005634 (nucleus) is_active_in
- GO:0000978 (RNA polymerase II cis-regulatory region sequence-specific DNA binding)
- GO:0006357 (regulation of transcription by RNA polymerase II)
- GO:0007259 (cell surface receptor signaling pathway via JAK-STAT)
- GO:0000981 (DNA-binding transcription factor activity, RNA polymerase II-specific)

Recommendation:
- Action: ACCEPT most with caveats on specific terms
- Rationale:
- Rows 5, 7, 9: ACCEPT (nuclear localization, transcription regulation, TF activity are core)
- Row 8 (JAK-STAT pathway): MODIFY to note that C. elegans lacks JAK but uses SNF-12 instead. Consider GO:0007165 (signal transduction) as substitute or annotation to modified pathway term if available.
- Row 4 (cell proliferation): KEEP_AS_NON_CORE (phylogenetically inferred but undemonstrated in C. elegans sta-2)
- Rows 2-3: ACCEPT (constitutive localization to cytoplasm and nucleus appropriate for STAT protein shuttling)

ISSUE 2: Defense Response Annotations - Core Functions

Annotations to ACCEPT:
- GO:0050832 (defense response to fungus) - row 21 (IMP, PMID:22470487)
- GO:0006952 (defense response) - row 3 (IBA but well-supported by IMP below)
- GO:0009611 (response to wounding) - row 19 (IMP, PMID:22470487)
- GO:0010628 (positive regulation of gene expression) - row 20 (IMP, PMID:22470487) in immune context

Recommendation:
- Action: ACCEPT all
- Rationale: These are core STA-2 functions with solid experimental evidence. PMID:22470487 is key study on sta-2 in epidermal immunity.

ISSUE 3: Problematic Cellular Component Annotations

Annotations present:
- GO:0030056 (hemidesmosome) located_in - row 23 (IDA, PMID:25692704)
- GO:0098733 (hemidesmosome associated protein complex) part_of - row 24 (IDA, PMID:25692704)
- GO:0030139 (endocytic vesicle) located_in - row 26 (IDA, PMID:21575913)
- GO:0045177 (apical part of cell) located_in - row 27 (IDA, PMID:21575913)

Recommendation:
- Action: KEEP_AS_NON_CORE or MODIFY relationships
- Rationale: STA-2's localization at hemidesmosomes is mechanistically important for understanding how it's sequestered and activated (row 23 well-supported by PMID:25692704). However, these represent structural/localization details rather than functional roles. Keep IDA annotations but categorize as non-core cellular context annotations. Rows 26-27 (endocytic vesicle, apical part) may reflect trafficking/localization during activation - keep but note as secondary.

ISSUE 4: Antimicrobial Peptide Production Annotation

Annotation present:
- GO:0002804 (positive regulation of antifungal peptide production) - row 28 (IMP, PMID:21575913)

Recommendation:
- Action: ACCEPT as core
- Rationale: This is the primary functional readout of STA-2 activation. PMID:21575913 demonstrates sta-2 is required for nlp-29 (antifungal peptide) induction upon infection. This is a key core annotation.

ISSUE 5: Transcription Factor DNA Binding Annotations

Annotations present:
- GO:0000978 (RNA pol II cis-regulatory region binding) - rows 6, 42 (IBA, IDA)
- GO:0000981 (DNA-binding transcription factor activity, RNA pol II-specific) - row 9 (IBA)
- GO:0003677 (DNA binding) - row 10 (IEA)
- GO:0003700 (DNA-binding transcription factor activity) - row 11 (IEA)

Recommendation:
- Action: CONSOLIDATE and ACCEPT
- Rationale: Multiple overlapping DNA binding annotations. Keep GO:0000978 (most specific to Pol II cis-elements for STA-2 targets like nlp-29) with both IBA (phylogenetic) and IDA (PMID:21575913 demonstrates nlp-29 binding). Rows 10-11 are broader parent terms; acceptable but less informative than row 6.

ISSUE 6: Generic Regulatory Annotations

Annotations present:
- GO:0006351 (DNA-templated transcription) - row 14 (IEA)
- GO:0006355 (regulation of DNA-templated transcription) - row 15 (IEA)
- GO:0007165 (signal transduction) - row 16 (IEA via InterPro)

Recommendation:
- Action: MODIFY or REMOVE
- Rationale: These are too generic for a specific transcription factor. STA-2's function is not general signal transduction or transcription regulation, but specifically regulation of antimicrobial peptide genes in response to infection. Prefer GO:0002804 (antifungal peptide production) or similar specific terms.

ISSUE 7: IEA Annotations - General Quality

Annotations: Rows 10-17 (IEA from various sources: UniProt-KW, InterPro)

Recommendation:
- Action: ACCEPT with notes
- Rationale: IEA annotations are appropriate for general transcription factor functions (DNA binding, nuclear localization) inferred from domain structure. However, prioritize IMP/IDA annotations for core epidermal immunity function.

Action Count GO Terms Evidence
ACCEPT (core immune) ~6 GO:0050832, GO:0002804, GO:0009611, GO:0010628 IMP, IDA
KEEP_AS_NON_CORE ~5 Hemidesmosome localization, trafficking, proliferation IDA, IEA, IBA
MODIFY ~3 JAK-STAT pathway (note C. elegans difference), broad regulatory terms IBA, IEA
CONSOLIDATE ~3 Multiple DNA binding terms (keep GO:0000978 primarily) IBA, IDA, IEA

4. NIPI-3 (G5EED4) - Tribbles Pseudokinase Adapter (18 annotations)

Gene Summary

NIPI-3 is a Tribbles family pseudokinase that functions as a regulatory adapter in innate immune signaling and developmental pathways. Despite containing a kinase domain, it lacks catalytic activity (pseudokinase). NIPI-3 functions upstream of p38 MAPK (pmk-1/sek-1) pathway in epidermal antifungal immunity and negatively regulates CEBP-1 in intestinal immunity against bacteria. NIPI-3 directly interacts with CEBP-1 transcription factor. Developmentally, loss of nipi-3 causes larval arrest, indicating essential developmental role.

Overall Assessment

The 18 annotations appropriately capture NIPI-3's adapter functions in immunity and development. The collection is well-balanced, but requires careful distinction between core immune functions and developmental roles.

Key Curation Issues

ISSUE 1: Nuclear Localization Annotation

Annotation present:
- GO:0005634 (nucleus) is_active_in - row 2 (IBA)
- GO:0005634 (nucleus) located_in - row 8 (IEA)

Recommendation:
- Action: ACCEPT and CONSOLIDATE
- Rationale: NIPI-3 is nuclear-localized in epidermis, intestine, and neurons (PMID:27927209). Both annotations are correct; IBA (phylogenetic) and IEA (subcellular location prediction) are consistent. Could consolidate to single IDA entry if available from PMID:27927209.

ISSUE 2: MAPK Kinase Binding Annotation

Annotation present:
- GO:0031434 (mitogen-activated protein kinase kinase binding) - row 3 (IBA)

Recommendation:
- Action: ACCEPT with caveats
- Rationale: IBA annotation is phylogenetically reasonable (mammalian Tribbles proteins bind MAPK components). Genetic evidence (PMID:27927209 shows sek-1 suppresses nipi-3 lethality) supports functional interaction with MAPKK. Direct physical binding not demonstrated in C. elegans but phylogenetically inferred and functionally supported.

ISSUE 3: Proteasome Regulation Annotation

Annotation present:
- GO:0032436 (positive regulation of proteasomal ubiquitin-dependent protein catabolic process) - row 4 (IBA)

Recommendation:
- Action: KEEP_AS_NON_CORE or REMOVE
- Rationale: Mammalian Tribbles do promote C/EBP degradation via ubiquitin-proteasome. However, in C. elegans, NIPI-3 regulates CEBP-1 transcriptionally rather than post-translationally (PMID:27927209). A translational reporter showed no differences in nipi-3 mutants, indicating proteasomal degradation is NOT the primary mechanism. Mark as non-core or remove as not demonstrated for C. elegans NIPI-3.

ISSUE 4: ATP/Nucleotide Binding Annotations

Annotations present:
- GO:0000166 (nucleotide binding) - row 5 (IEA)
- GO:0004672 (protein kinase activity) - row 6 (IEA)
- GO:0005524 (ATP binding) - row 7 (IEA)

Recommendation:
- Action: MODIFY or REMOVE
- Rationale: NIPI-3 is a pseudokinase lacking catalytic residues. While it contains kinase domain topology and ATP binding pocket (row 7 IEA based on InterPro kinase domain), it does NOT have kinase activity (row 6 should be removed). The nucleotide binding is predicted from domain structure but unclear if ATP actually binds functionally. Recommend:
- Row 7 (ATP binding): KEEP as structural feature but note that kinase activity is absent
- Row 6 (kinase activity): REMOVE (pseudokinase, not active)
- Row 5 (nucleotide binding): KEEP but note as predicted, not experimentally validated

ISSUE 5: Immune Response Annotations - Core Functions

Annotations to ACCEPT:
- GO:0010468 (regulation of gene expression) - row 9 (IMP, PMID:27927200)
- GO:0010629 (negative regulation of gene expression) - rows 10, 13 (IMP)
- GO:0050829 (defense response to Gram-negative bacterium) - row 11 (IMP, PMID:27927200)
- GO:0050830 (defense response to Gram-positive bacterium) - row 12 (IMP, PMID:34407394)
- GO:0010628 (positive regulation of gene expression) - row 15 (IMP, PMID:18394898)
- GO:0050832 (defense response to fungus) - rows 16, 18 (IMP, PMID:18394898 and PMID:22470487)
- GO:0061760 (antifungal innate immune response) - row 17 (IMP, PMID:18394898)

Recommendation:
- Action: ACCEPT all
- Rationale: These are core NIPI-3 immune functions with solid IMP evidence. The annotations appropriately capture both epidermal antifungal immunity (GO:0061760) and intestinal bacterial defense (GO:0050829, GO:0050830).

ISSUE 6: Transcription Factor Binding Annotation

Annotation present:
- GO:0140297 (DNA-binding transcription factor binding) - row 14 (IPI, PMID:27927209 with UniProtKB:Q18909)

Recommendation:
- Action: ACCEPT
- Rationale: This is the well-documented NIPI-3-CEBP-1 interaction. PMID:27927209 demonstrates direct interaction with CEBP-1 (Q18909). This is a core mechanistic annotation.

ISSUE 7: Developmental (Non-core) Annotations

Note: The provided GOA file only shows up to row 18. Based on context in existing review, there may be developmental annotations related to larval lethality/arrest that would be KEEP_AS_NON_CORE.

Action Count GO Terms Evidence
ACCEPT (core immune) ~7 GO:0050829, GO:0050830, GO:0050832, GO:0061760, antifungal pathway IMP
KEEP_AS_NON_CORE ~2 ATP binding (domain), possibly developmental IEA
REMOVE ~2 Kinase activity (pseudokinase), proteasome regulation IEA
MODIFY ~2 Nucleotide binding (note pseudokinase context), MAPKK binding (note c. elegans specificity) IEA, IBA

5. LYS-7 (O16202) - Lysozyme-like Protein (18 annotations)

Gene Summary

LYS-7 is a protist-type (Entamoeba-like) lysozyme belonging to glycosyl hydrolase family 25. Despite containing a Ch-type lysozyme domain, LYS-7 lacks conserved catalytic residues and likely lacks enzymatic activity. It functions as a key antimicrobial effector in C. elegans immunity. LYS-7 is expressed in intestine, rectal glands, and neurons, induced by diverse pathogens (S. marcescens, M. nematophilum, S. typhimurium), and provides resistance against Gram-positive bacteria (B. thuringiensis) and fungi (C. neoformans). Paradoxically, lys-7 knockout animals show increased tolerance to S. typhimurium, suggesting complex immunological trade-offs. Expression is regulated by p38 MAPK and DAF-2/DAF-16 insulin signaling.

Overall Assessment

The 18 annotations appropriately capture LYS-7's role as a core antimicrobial effector. The collection is well-curated with good balance of molecular function, biological process, and cellular component annotations. Most annotations are appropriately specific to immunity function.

Key Curation Issues

ISSUE 1: Phylogenetic Inference Annotation - Signal Transduction

Annotation present:
- GO:0007165 (signal transduction) - row 2 (IBA, GO_REF:0000033)

Recommendation:
- Action: REMOVE
- Rationale: LYS-7 is an antimicrobial effector molecule whose EXPRESSION is regulated by signal transduction pathways (p38 MAPK, insulin signaling), but the protein itself does NOT participate in signal transduction. It's a DOWNSTREAM EFFECTOR, not a signaling component. This annotation is incorrect even though based on phylogenetic inference to other lysozymes. The annotation likely results from broad InterPro/PANTHER inference that doesn't distinguish between regulatory inputs and functional outputs.

ISSUE 2: IBA Annotations Quality Check

Annotations present:
- GO:0045087 (innate immune response) - row 3 (IBA, GO_REF:0000033)
- Same term, row 9 (IEA, UniProt-KW)

Recommendation:
- Action: ACCEPT (keep both or consolidate to IBA as primary)
- Rationale: IBA is phylogenetically sound for a lysozyme in immune context. The duplication (rows 3, 9) is redundant. Consolidate to keep one entry with strongest evidence.

ISSUE 3: Enzyme Activity Annotations

Annotations present:
- GO:0003796 (lysozyme activity) - row 5 (IEA, InterPro:IPR002053)

Recommendation:
- Action: MODIFY or REMOVE
- Rationale: LYS-7 contains a lysozyme domain (IPR002053) but LACKS key catalytic residues. It's non-catalytic. The IEA annotation should be MODIFIED to note that the domain is present but non-functional, OR remove the annotation as enzymatic activity annotation is misleading. This is a critical issue. If keeping, annotate with evidence qualifier noting lack of catalytic activity.
- Alternative: Replace with GO:0051183 (auxin binding) if applicable, but more likely this should be removed entirely or replaced with a binding-related term that doesn't imply catalytic function.

ISSUE 4: Catabolic Process Annotations

Annotations present:
- GO:0009253 (peptidoglycan catabolic process) - row 7 (IEA, InterPro:IPR002053)
- GO:0016998 (cell wall macromolecule catabolic process) - row 8 (IEA, InterPro:IPR002053)

Recommendation:
- Action: REMOVE or MODIFY
- Rationale: These annotations infer that LYS-7 CATALYZES peptidoglycan breakdown based on domain similarity to active lysozymes. However, LYS-7 lacks catalytic activity. These annotations are MISLEADING. Either:
a) REMOVE entirely (LYS-7 likely functions through non-catalytic mechanisms like binding/agglutination)
b) MODIFY to GO:0030246 (carbohydrate binding) if it binds but doesn't cleave bacterial cell walls
c) Annotate to broader GO:0050826 (natural killer cell mediated immunity) or similar if function is opsonization-like

This is a critical curation point where domain-based inference leads to incorrect annotation.

ISSUE 5: Core Immune Response Annotations

Annotations to ACCEPT:
- GO:0050830 (defense response to Gram-positive bacterium) - rows 10-12 (IMP, multiple studies)
- GO:0050832 (defense response to fungus) - row 13 (IMP, PMID:21399680)
- GO:0050829 (defense response to Gram-negative bacterium) - rows 14, 18 (IMP, IGI)
- GO:0045087 (innate immune response) - rows 3, 9, 16 (IBA, IEA, IMP)

Recommendation:
- Action: ACCEPT all
- Rationale: These are well-supported by multiple independent studies (PMID:16809667, PMID:21931778, PMID:21399680, PMID:19023415, PMID:18927620). These represent core LYS-7 functions and should be retained.

ISSUE 6: Response to Stress Annotation

Annotation present:
- GO:0006950 (response to stress) - row 6 (IEA, ARBA:ARBA00026300)

Recommendation:
- Action: KEEP_AS_NON_CORE
- Rationale: LYS-7 expression is stress-responsive (up-regulated during pathogen exposure), but "response to stress" is a broad parent term. More specific immune response annotations (rows 10-18) are preferred. Keep but note as redundant with more specific child terms.

ISSUE 7: Immune System Process vs. Innate Immune Response Redundancy

Annotations present:
- GO:0002376 (immune system process) - row 4 (IEA, UniProt-KW:KW-0391)
- GO:0045087 (innate immune response) - rows 3, 9, 16 (IBA, IEA, IMP)

Recommendation:
- Action: ACCEPT both or CONSOLIDATE
- Rationale: GO:0002376 is a parent term of GO:0045087. The IEA annotation to GO:0002376 is correct but less specific. Keep both or consolidate to GO:0045087. Given that more specific immune annotations exist, row 4 is somewhat redundant but acceptable.

Action Count GO Terms Evidence
ACCEPT (core immune) ~8-10 GO:0050830, GO:0050832, GO:0050829, GO:0045087 IMP, IEA, IBA
REMOVE ~3 Signal transduction (not effector role), lysozyme activity (non-catalytic), peptidoglycan catabolic (non-catalytic) IBA, IEA
MODIFY ~1 Catabolic annotations to binding term if applicable IEA
KEEP_AS_NON_CORE ~2 Stress response (redundant), immune system process (parent term) IEA

6. CLEC-60 (Q23564) - C-type Lectin (1 annotation)

Gene Summary

CLEC-60 is a secreted C-type lectin domain-containing protein with a von Willebrand factor type A (VWA) domain that functions as an antimicrobial effector in C. elegans innate immunity. It is strongly upregulated (8.3-fold) in intestinal epithelial cells during Staphylococcus aureus infection and provides protective effects through overexpression. Contains a signal peptide for secretion and is classified as an antimicrobial effector with predicted carbohydrate-binding function. Also induced by other pathogens including P. aeruginosa and M. nematophilum.

Overall Assessment

Only 1 GOA annotation exists, making this the least-annotated gene in this set. The existing annotation is well-supported. This gene requires expansion of annotations to capture its full function. The existing review file (clec-60-ai-review.yaml) proposes NEW annotations that should be integrated into the GOA.

Existing Annotation Assessment

Current Annotation:

Status: ACCEPT
Rationale: Well-supported by PMID:20617181 showing clec-60 upregulation and overexpression protection during S. aureus infection. IGI evidence is appropriate (genetic interaction with clec-61).

Proposed Annotations from Existing Review

The clec-60-ai-review.yaml file proposes 3 NEW annotations worth implementing:

  1. GO:0030246 (carbohydrate binding) - NEW (IEA, InterPro domain)
  2. Rationale: C-type lectin domain is characterized by carbohydrate-binding activity
  3. Mechanism: Calcium-dependent recognition of pathogen surface carbohydrates

  4. Status: RECOMMEND ADDING

  5. GO:0140367 (antibacterial innate immune response) - NEW (IMP, PMID:20617181)

  6. Rationale: Broader characterization of CLEC-60's immune function
  7. Evidence: Transcriptional induction, overexpression protection

  8. Status: RECOMMEND ADDING

  9. GO:0005576 (extracellular region) - NEW (IEA, signal peptide)

  10. Rationale: Signal peptide indicates secretion
  11. Mechanism: Consistent with antimicrobial effector function
  12. Status: RECOMMEND ADDING
Action Count GO Terms Evidence
ACCEPT 1 GO:0050830 IGI
ADD (NEW) 3 GO:0030246, GO:0140367, GO:0005576 IEA, IMP

Cross-Gene Patterns and General Recommendations

Pattern 1: Generic "Protein Binding" Annotations Should Be Removed or Specified

Affected genes: DAF-16 (8-9 entries), possibly others
Recommendation: Systematically replace GO:0005515 with specific binding terms or remove if not mechanistically relevant. Examples of specific alternatives:
- GO:0071889 (14-3-3 protein binding)
- GO:0140297 (DNA-binding transcription factor binding)
- GO:0008013 (beta-catenin binding)
- GO:0019899 (enzyme binding)
- GO:0031625 (ubiquitin protein ligase binding)

Pattern 2: Phylogenetic (IBA) vs. Experimental Evidence Priority

Recommendation: For all genes, prioritize IMP/IGI/IDA evidence when available over IBA. Flag IBA annotations that lack experimental support or that might not translate to C. elegans-specific functions (e.g., sta-2 lacks JAK-STAT machinery).

Pattern 3: Developmental/Pleiotropic Roles Should Be Categorized as NON-CORE for Immunity-Focused Review

Affected genes: DAF-16 (extensive), DBL-1 (growth), NIPI-3 (larval arrest)
Recommendation: Use KEEP_AS_NON_CORE action for well-documented developmental roles to distinguish core immune functions.

Pattern 4: Over-annotation of Broad Process Terms

Affected genes: DAF-16, DBL-1, STA-2
Pattern: GO:0010468 (regulation of gene expression), GO:0006355 (regulation of DNA-templated transcription), GO:0006351 (DNA-templated transcription)
Recommendation: These are too general for specific regulatory proteins. Prefer specific process terms (e.g., GO:0002804 for antifungal peptide production rather than GO:0010468).

Pattern 5: Domain-Based Inference for Inactive/Catalytic Annotations

Affected genes: LYS-7 (lysozyme activity, catabolic processes), NIPI-3 (kinase activity)
Pattern: InterPro/domain-based (IEA) annotations for enzymatic activity in pseudoenzymes/non-catalytic proteins
Recommendation:
- Systematically review all IEA annotations based on enzyme domains for pseudoenzymes
- Remove catalytic annotations for proteins confirmed to lack catalytic activity
- Replace with binding or regulatory annotations if appropriate
- This is a critical quality control point

Pattern 6: Localization Annotations - Standardize Relationships

Affected genes: DAF-16 (multiple nucleus/cytoplasm entries), STA-2 (hemidesmosome)
Pattern: Multiple relationship types (is_active_in, located_in, colocalizes_with) for same location
Recommendation: Consolidate and standardize relationship types:
- Use is_active_in for functional compartments (nucleus for transcription factors)
- Use located_in for structural/steady-state localization
- Consolidate redundant entries, preferring IDA over IEA/NAS

Pattern 7: Duplicate Entries Across Genes

Affected: DBL-1 (rows 15-16 both GO:0050829)
Recommendation: Systematic deduplication pass. Keep one entry per unique GO term + evidence combination.

Pattern 8: Evidence Code Quality Check

Specific recommendations:
- IMP (Mutant Phenotype): Generally high quality; check that phenotypes are specific to target gene
- IGI (Genetic Interaction): Generally high quality; verify that With/From genes are correctly identified
- IPI (Protein Interaction): Verify interactions are mechanistically relevant and not high-throughput noise
- IDA (Direct Assay): Highest quality; prioritize these when available
- IEA (Electronic Annotation): Lower priority unless no manual evidence exists
- IEP (Expression Pattern): Generally weak; use only when combined with other evidence
- NAS (Narrative Statement): Weak; should be backed up by more rigorous evidence codes

Implementation Recommendations

Phase 1: High-Priority Critical Fixes (Week 1)

  1. CLEC-60: Add 3 proposed NEW annotations (GO:0030246, GO:0140367, GO:0005576)
  2. LYS-7: Remove signal transduction annotation (GO:0007165); review and fix lysozyme activity and catabolic annotations
  3. NIPI-3: Remove kinase activity annotation (GO:0004672); review proteasome annotation
  4. DAF-16: Remove/consolidate 8-9 generic protein binding annotations
  5. DBL-1: Consolidate duplicate rows 15-16 (GO:0050829)

Phase 2: Comprehensive Curation (Week 2-3)

  1. DAF-16:
  2. Consolidate 13+ lifespan annotations
  3. Categorize developmental annotations as NON-CORE
  4. Standardize localization annotations

  5. Replace broad gene regulation terms with specific processes

  6. STA-2:

  7. Modify JAK-STAT pathway annotation to note C. elegans-specific mechanism
  8. Consolidate DNA binding annotations

  9. Categorize hemidesmosome localization as NON-CORE

  10. NIPI-3:

  11. Flag ATP binding annotation as pseudokinase context

  12. Evaluate developmental annotations

  13. DBL-1:

  14. Categorize growth/development as NON-CORE
  15. Consolidate regulatory process annotations

Phase 3: Quality Control & Validation (Week 4)

  1. Cross-check all evidence codes against cited publications
  2. Validate that GeneIDs in With/From fields are correct (especially IGI entries)
  3. Ensure relationship types (involved_in, enables, acts_upstream_of, etc.) are correct
  4. Final review of immunity vs. non-core categorization consistency across all 6 genes
Gene Annotations ACCEPT REMOVE MODIFY KEEP_NON_CORE CONSOLIDATE NEW
daf-16 144 15-18 5-8 5 20 15 0
dbl-1 32 8-10 0-1 1 10 2 0
sta-2 27 6 0 3 5 3 0
nipi-3 18 7 2 2 2 1 0
lys-7 18 8-10 3 1 2 1 0
clec-60 1 1 0 0 0 0 3
TOTAL 238 ~45-53 10-14 12 ~39 22 3

File Paths for Review Updates

GOA TSV Files (Read-only reference):

AI Review YAML Files (To be updated):

Supporting Resources:

Key References Consulted

This review synthesizes information from:
- Existing GO annotation files (GOA TSV format)
- Existing AI review YAML files
- Deep research summaries (Falcon provider)
- UniProt protein records
- Relevant primary literature in publications/ directory

Key primary studies cited multiple times across genes:
- Innate immunity: PMID:19198592, PMID:19454349, PMID:21575913, PMID:22470487
- Dauer/development: PMID:11747825, PMID:11381260, PMID:23665919
- BMP/Growth: PMID:9847238, PMID:12397107, PMID:12717735
- Lysozymes: PMID:16809667, PMID:21931778, PMID:21399680
- Tribbles/NIPI: PMID:18394898, PMID:27927200, PMID:27927209
- C-type lectins: PMID:20617181

Final Notes

This curation review emphasizes:

  1. Domain-based inference is error-prone for pseudoenzymes and inactive proteins. The most critical issues are LYS-7 lysozyme activity and NIPI-3 kinase activity annotations that infer function from domain similarity despite lack of catalytic activity.

  2. Phylogenetic inference (IBA) must be validated experimentally in C. elegans context. Several IBA annotations (e.g., sta-2 JAK-STAT pathway, NIPI-3 proteasome regulation) assume conservation that doesn't hold for C. elegans-specific biology.

  3. Generic binding annotations reduce annotation informativeness. Systematic replacement of GO:0005515 with specific interactions improves curation quality.

  4. Pleiotropic gene functions require careful prioritization. DAF-16 and DBL-1 have legitimate developmental roles that should be retained but clearly marked as NON-CORE in immunity-focused curation.

  5. Duplicate and redundant annotations should be consolidated. The large annotation sets (especially daf-16 with 144) contain systematic redundancy that could be reduced without loss of information.